RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 190 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,559,469 | -38.2% | 465,290 | -39.6% | 0.00% | -100.0% |
| Q2 2023 | $5,757,562 | +32.7% | 770,758 | +18.4% | 0.00% | 0.0% |
| Q1 2023 | $4,340,269 | -28.9% | 650,715 | -17.8% | 0.00% | 0.0% |
| Q4 2022 | $6,102,851 | +7.8% | 791,550 | +48.7% | 0.00% | 0.0% |
| Q3 2022 | $5,663,000 | +98.0% | 532,370 | +51.5% | 0.00% | 0.0% |
| Q2 2022 | $2,860,000 | -57.1% | 351,372 | -62.3% | 0.00% | 0.0% |
| Q1 2022 | $6,666,000 | +79.3% | 931,070 | +329.1% | 0.00% | 0.0% |
| Q4 2021 | $3,718,000 | +327.4% | 217,007 | +474.1% | 0.00% | – |
| Q3 2021 | $870,000 | +278.3% | 37,800 | +500.0% | 0.00% | – |
| Q2 2021 | $230,000 | – | 6,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Data Collective IV GP, LLC | 5,941,120 | $45,806,035 | 48.11% |
| Kinnevik AB (publ) | 7,653,061 | $59,005,100 | 33.28% |
| MV Management XI, L.L.C. | 1,971,908 | $15,203,411 | 26.45% |
| MIC Capital Management UK LLP | 8,451,758 | $65,163,057 | 12.86% |
| ArchPoint Investors | 1,114,626 | $8,593,766 | 4.07% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $11,636,348 | 1.44% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,710,339 | $20,896,714 | 0.80% |
| Duquesne Family Office | 1,385,950 | $10,685,675 | 0.53% |
| ALLEN OPERATIONS LLC | 217,657 | $1,678,135 | 0.45% |
| Artal Group S.A. | 960,204 | $7,403 | 0.41% |